Mackenzie Financial Corp raised its stake in shares of Bain Capital Specialty Finance, Inc. (NYSE:BCSF - Free Report) by 418.8% during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 104,816 shares of the company's stock after acquiring an additional 84,613 shares during the period. Mackenzie Financial Corp owned about 0.16% of Bain Capital Specialty Finance worth $1,740,000 as of its most recent SEC filing.
Other hedge funds also recently made changes to their positions in the company. Cambridge Investment Research Advisors Inc. grew its holdings in shares of Bain Capital Specialty Finance by 11.5% during the first quarter. Cambridge Investment Research Advisors Inc. now owns 54,548 shares of the company's stock worth $906,000 after purchasing an additional 5,618 shares in the last quarter. Envestnet Asset Management Inc. increased its position in shares of Bain Capital Specialty Finance by 5.2% during the first quarter. Envestnet Asset Management Inc. now owns 346,923 shares of the company's stock valued at $5,759,000 after buying an additional 17,050 shares during the period. Invesco Ltd. increased its position in shares of Bain Capital Specialty Finance by 25.2% during the fourth quarter. Invesco Ltd. now owns 75,536 shares of the company's stock valued at $1,323,000 after buying an additional 15,185 shares during the period. Raymond James Financial Inc. purchased a new stake in Bain Capital Specialty Finance in the fourth quarter worth $1,482,000. Finally, Comerica Bank grew its stake in Bain Capital Specialty Finance by 8.2% in the fourth quarter. Comerica Bank now owns 17,029 shares of the company's stock worth $298,000 after purchasing an additional 1,292 shares during the period.
Bain Capital Specialty Finance Price Performance
BCSF traded up $0.14 on Tuesday, hitting $14.82. 341,302 shares of the company's stock traded hands, compared to its average volume of 237,471. The company's 50 day simple moving average is $15.27 and its 200-day simple moving average is $16.10. The firm has a market cap of $961.37 million, a price-to-earnings ratio of 8.52 and a beta of 0.83. Bain Capital Specialty Finance, Inc. has a one year low of $13.20 and a one year high of $19.21. The company has a current ratio of 3.69, a quick ratio of 3.69 and a debt-to-equity ratio of 1.27.
Bain Capital Specialty Finance (NYSE:BCSF - Get Free Report) last released its quarterly earnings data on Tuesday, August 5th. The company reported $0.47 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.43 by $0.04. Bain Capital Specialty Finance had a return on equity of 11.62% and a net margin of 39.60%. As a group, research analysts anticipate that Bain Capital Specialty Finance, Inc. will post 2.06 EPS for the current year.
Bain Capital Specialty Finance Announces Dividend
The company also recently disclosed a dividend, which was paid on Monday, June 30th. Shareholders of record on Tuesday, June 17th were paid a $0.03 dividend. The ex-dividend date of this dividend was Monday, June 16th. This represents a yield of 1,166.0%. Bain Capital Specialty Finance's payout ratio is presently 96.55%.
Wall Street Analyst Weigh In
BCSF has been the topic of a number of recent research reports. Wells Fargo & Company cut their target price on Bain Capital Specialty Finance from $19.00 to $16.00 and set an "overweight" rating on the stock in a research note on Monday, April 28th. Keefe, Bruyette & Woods lowered their target price on Bain Capital Specialty Finance from $18.00 to $17.00 and set a "market perform" rating on the stock in a report on Tuesday, April 8th.
Read Our Latest Report on Bain Capital Specialty Finance
Bain Capital Specialty Finance Company Profile
(
Free Report)
Bain Capital Specialty Finance, Inc is business development company specializing in direct loans to middle-market companies. The fund seeks to invest in senior investments with a first or second lien on collateral, senior first lien, stretch senior, senior second lien, unitranche, mezzanine debt, junior securities, other junior investments, and secondary purchases of assets or portfolios that primarily consist of middle-market corporate debt.
Further Reading

Before you consider Bain Capital Specialty Finance, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bain Capital Specialty Finance wasn't on the list.
While Bain Capital Specialty Finance currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.